Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Ciphergen, Sanofi-Aventis Enter Biomarker Collaboration | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Ciphergen, Sanofi-Aventis Enter Biomarker Collaboration

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Ciphergen has signed a collaborative research agreement with Sanofi-Aventis, extending its existing relationship. The project will concentrate on discovery, validation, and identification of biomarkers for a preclinical drug efficacy study in the field of oncology. Under the terms of the agreement, Ciphergen will analyze samples at one of its Biomarker Discovery Center laboratories using its suite of proteomic solutions. Financial terms were not disclosed.

“We are extremely pleased to be partnering with Sanofi-Aventis, an organization committed to innovation which shares our vision to accelerate and streamline development of new drugs through the early identification of relevant drug efficacy biomarkers,” stated Gail S. Page, president and chief executive officer of Ciphergen. “The partnership allows Sanofi-Aventis access to our expert scientists and latest technologies and is an important addition to our translational proteomics partnerships for drug discovery and development.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics